Drug Database
Back to search

United States· US:42806-299_e9957997-8b85-48a0-9bb3-b878cb223236

Nizatidine

A nizatidine product containing nizatidine, registered in United States by Epic Pharma, LLC. The same ATC class is registered in 5 of our 19 countries.

ATC A02BA04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNizatidineATCA02BA04REGISTER NO.US:42806-299_e9957997…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nizatidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nizatidine is registered in 5 of 19 countries.

Countries holding a registration under ATC A02BA04 (nizatidine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose
Search nizatidine products by name

Nizatidine · ATC A02BA04

5 / 19 countries

  • Canada
  • Finlandprice
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NIZATIDINE
Manufacturer
Epic Pharma, LLC
Country
United States (US)
ATC code
A02BA04
ATC class
Nizatidine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    4280629930
    30 CAPSULE in 1 BOTTLE (42806-299-30)
  • ndc11
    4280629960
    60 CAPSULE in 1 BOTTLE (42806-299-60)
  • ndc11
    42806-299-30
  • ndc11
    42806-299-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

346 interactions on record for nizatidine.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nizatidine against other medicinesHow interaction checks work

Nizatidine · interactions on record

346 records

  • 11 severe
  • 52 moderate
  • 49 minor
  • 233 info

Most severe, free to view

  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe
  • DasatinibL01EA02severe
  • NeratinibL01EH02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nizatidine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nizatidine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • United Kingdom (Northern Ireland) · Nizatidine, Nizatidine Generics Uk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/64132018-eba1-4d17-a1d5-a13973827712
GET /v1/drugs/64132018-eba1-4d17-a1d5-a13973827712?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "150",
  "substance": "NIZATIDINE",
  "productndc": "42806-299",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA076178",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about nizatidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console